Medical Device Nonvisual Accessibility Act of 2023

This bill requires the Food and Drug Administration (FDA) to establish accessibility standards for medical devices that use digital screens or interfaces, such as insulin pumps or blood pressure monitors. Under this legislation, manufacturers of moderate- to high-risk devices would be required to ensure that blind or low-vision individuals can access the same information and features as other users, typically through audio or tactile feedback. These requirements would apply to devices intended for home use, ensuring that patients with visual impairments can manage their health independently and safely.